TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
MRK

Merck & Company Inc

Healthcare · Drug Manufacturers - General

148.10$ -1.9% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Income Statement

Merck & Company Inc (MRK) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 16,607 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement MRK
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
10,536 10,115 9,434 9,930 10,325 10,433 10,037 10,465 10,794 10,998 10,816 11,760 12,397 11,868 12,057 9,353 10,929 12,515 10,627 11,402 13,154 13,521 15,901 14,593 14,959 13,830 14,487 15,035 15,962 14,630 15,775 16,112 16,657 15,624 15,619 15,800 17,183 16,324 16,286 16,607 66,400
3,409 3,332 3,049 3,116 3,307 3,406 3,184 3,417 3,619 3,289 3,052 3,401 3,990 3,669 3,312 2,747 3,013 5,533 3,199 3,104 3,450 3,874 5,380 4,216 3,934 3,881 3,926 4,024 4,264 3,912 3,540 3,745 4,080 3,828 3,885 3,847 4,194 4,817 2,944 4,395 16,350
7,127 6,783 6,385 6,814 7,018 7,027 6,853 7,048 7,175 7,709 7,764 8,359 8,407 8,199 8,745 6,606 7,916 6,982 7,428 8,298 9,704 9,647 10,521 10,377 11,025 9,949 10,561 11,011 11,698 10,718 12,235 12,367 12,577 11,796 11,734 11,953 12,989 11,507 13,342 12,212 50,050
1,664 4,649 1,830 1,782 4,413 2,281 3,196 2,274 2,068 2,214 1,931 2,189 3,204 2,548 2,209 2,085 3,349 5,837 2,412 4,321 2,445 3,068 2,576 2,798 4,399 3,775 4,276 13,321 3,307 9,627 3,992 3,500 5,862 4,584 3,119 3,540 3,552 2,499 12,558 9,741 28,350
2,393 2,593 2,411 2,438 2,401 2,580 2,508 2,508 2,443 543 2,425 2,712 2,589 789 2,555 2,378 2,450 1,285 2,633 2,281 2,336 830 2,323 2,512 2,520 487 2,458 2,625 2,519 341 2,483 2,739 2,731 291 2,552 2,633 2,633 2,848 2,700 2,904 11,085
4,057 7,242 4,302 4,282 6,872 4,860 5,704 4,782 4,511 4,857 4,356 4,901 5,793 5,437 4,764 4,170 5,409 8,922 4,599 6,602 4,781 5,898 4,899 5,310 6,919 6,462 6,755 16,023 5,826 12,431 10,015 6,239 8,593 7,448 5,024 5,594 5,526 5,347 15,226 12,895 38,994
3,070 -459 2,083 2,532 146 2,167 1,149 2,266 2,664 2,852 3,408 3,458 2,614 2,762 3,981 2,436 2,507 -1,940 2,829 1,696 4,923 3,749 5,622 5,067 4,106 3,487 3,806 -5,012 5,872 -1,713 5,760 6,128 3,984 4,348 6,710 6,359 7,463 6,160 -1,884 -683 11,056
170 180 182 193 189 190 185 194 190 203 209 233 231 219 212 209 203 207 200 202 196 209 243 240 244 235 242 277 317 310 303 310 330 328 313 305 327 411 479 525 1,742
2,887 -1,356 2,003 2,439 200 1,879 1,345 2,086 2,665 2,604 3,067 3,259 2,347 2,791 3,838 2,741 2,706 -1,993 2,987 1,717 5,266 3,909 4,861 4,487 3,583 3,513 3,650 -5,335 5,620 -2,046 5,670 6,006 4,090 4,170 5,903 4,999 6,745 3,420 -3,534 -683 5,948
699 -769 447 488 251 2,917 604 370 707 826 205 615 440 428 619 396 380 98 238 503 695 85 554 538 330 495 825 637 870 -820 – 545 929 426 818 571 958 458 709 654 2,779
2,184 -595 1,551 1,946 -56 -1,046 736 1,707 1,950 1,827 2,915 2,670 1,901 2,356 3,219 3,002 2,941 -2,094 3,179 1,545 4,567 3,758 4,310 3,944 3,248 3,017 2,821 -5,975 4,745 -1,226 4,762 5,455 3,157 3,743 5,079 4,427 5,785 2,963 -4,240 -1,335 3,173
4,232 -21 3,378 3,794 1,543 3,197 2,667 3,570 3,949 3,902 4,174 4,465 3,423 3,946 4,871 3,925 3,716 -882 4,079 2,647 6,221 4,953 6,224 5,665 4,786 4,640 4,883 -4,155 6,951 -772 6,744 7,448 5,606 5,695 7,315 6,360 8,144 6,297 -2,022 1,425 13,844

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?